Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013
- PMID: 27842997
- PMCID: PMC5590714
- DOI: 10.1016/j.fertnstert.2016.10.002
Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013
Abstract
Objective: To compare characteristics, explore predictors, and compare assisted reproductive technology (ART) cycle, transfer, and pregnancy outcomes of autologous and donor cryopreserved oocyte cycles with fresh oocyte cycles.
Design: Retrospective cohort study from the National ART Surveillance System.
Setting: Fertility treatment centers.
Patient(s): Fresh embryo cycles initiated in 2013 utilizing embryos created with fresh and cryopreserved, autologous and donor oocytes.
Intervention(s): Cryopreservation of oocytes versus fresh.
Main outcomes measure(s): Cancellation, implantation, pregnancy, miscarriage, and live birth rates per cycle, transfer, and/or pregnancy.
Result(s): There was no evidence of differences in cancellation, implantation, pregnancy, miscarriage, or live birth rates between autologous fresh and cryopreserved oocyte cycles. Donor cryopreserved oocyte cycles had a decreased risk of cancellation before transfer (adjusted risk ratio [aRR] 0.74, 95% confidence interval [CI] 0.57-0.96) as well as decreased likelihood of pregnancy (aRR 0.88, 95% CI 0.81-0.95) and live birth (aRR 0.87, 95% CI 0.80-0.95); however, there was no evidence of differences in implantation, pregnancy, or live birth rates when cycles were restricted to those proceeding to transfer. Donor cryopreserved oocyte cycles proceeding to pregnancy had a decreased risk of miscarriage (aRR 0.75, 95% CI 0.58-0.97) and higher live birth rate (aRR 1.05, 95% CI 1.01-1.09) with the transfer of one embryo, but higher miscarriage rate (aRR 1.28, 95% CI 1.07-1.54) and lower live birth rate (aRR 0.95, 95% CI 0.92-0.99) with the transfer of two or more.
Conclusion(s): There was no evidence of differences in ART outcomes between autologous fresh and cryopreserved oocyte cycles. There was evidence of differences in per-cycle and per-pregnancy outcomes between donor cryopreserved and fresh oocyte cycles, but not in per-transfer outcomes.
Keywords: Assisted reproductive technology (ART); egg freezing; in vitro fertilization (IVF); vitrification.
Published by Elsevier Inc.
Similar articles
-
Association of Fresh Embryo Transfers Compared With Cryopreserved-Thawed Embryo Transfers With Live Birth Rate Among Women Undergoing Assisted Reproduction Using Freshly Retrieved Donor Oocytes.JAMA. 2021 Jan 12;325(2):156-163. doi: 10.1001/jama.2020.23718. JAMA. 2021. PMID: 33433574 Free PMC article.
-
Pregnancy rates in donor oocyte cycles compared to similar autologous in vitro fertilization cycles: an analysis of 26,457 fresh cycles from the Society for Assisted Reproductive Technology.Fertil Steril. 2014 Aug;102(2):399-404. doi: 10.1016/j.fertnstert.2014.04.027. Epub 2014 May 17. Fertil Steril. 2014. PMID: 24842672
-
Preimplantation genetic testing for aneuploidy is associated with reduced live birth rates in fresh but not frozen donor oocyte in vitro fertilization cycles: an analysis of 18,562 donor cycles reported to Society for Assisted Reproductive Technology Clinic Outcome Reporting System.Fertil Steril. 2025 Jan;123(1):50-60. doi: 10.1016/j.fertnstert.2024.08.315. Epub 2024 Aug 10. Fertil Steril. 2025. PMID: 39128672
-
Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes.Cochrane Database Syst Rev. 2020 Oct 28;10(10):CD006359. doi: 10.1002/14651858.CD006359.pub3. Cochrane Database Syst Rev. 2020. PMID: 33112418 Free PMC article.
-
Evidence-based outcomes after oocyte cryopreservation for donor oocyte in vitro fertilization and planned oocyte cryopreservation: a guideline.Fertil Steril. 2021 Jul;116(1):36-47. doi: 10.1016/j.fertnstert.2021.02.024. Fertil Steril. 2021. PMID: 34148587 Review.
Cited by
-
Exploring the knowledge, attitudes, and perceptions of women of reproductive age towards fertility and elective oocyte cryopreservation for age-related fertility decline in the UK: a cross-sectional survey.Hum Reprod. 2023 Dec 4;38(12):2478-2488. doi: 10.1093/humrep/dead200. Hum Reprod. 2023. PMID: 37816663 Free PMC article.
-
An Update on Planned Oocyte Cryopreservation (POC) in Italy: Medical, Epidemiological and Legal Consideration.Int J Environ Res Public Health. 2022 Feb 18;19(4):2371. doi: 10.3390/ijerph19042371. Int J Environ Res Public Health. 2022. PMID: 35206556 Free PMC article. Review.
-
Cumulative live births and predictive factors of emergency oocyte cryopreservation: a retrospective cohort study.Reprod Biol Endocrinol. 2025 Jun 2;23(1):84. doi: 10.1186/s12958-025-01423-x. Reprod Biol Endocrinol. 2025. PMID: 40457462 Free PMC article.
-
Advanced Maternal Age Deteriorates the Developmental Competence of Vitrified Oocytes in Mice.Cells. 2021 Jun 21;10(6):1563. doi: 10.3390/cells10061563. Cells. 2021. PMID: 34205802 Free PMC article.
-
Clinical utilization and outcomes over eight consecutive years following oocyte cryopreservation.J Assist Reprod Genet. 2025 Feb;42(2):413-421. doi: 10.1007/s10815-024-03334-z. Epub 2024 Dec 4. J Assist Reprod Genet. 2025. PMID: 39633145
References
-
- Practice Committee of the American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertil Steril. 2013;99:37–43. - PubMed
-
- Barclay E. [Accessed December 16, 2015];More women are freezing their eggs, but will they ever use them? Shots: health news from NPR. Available at: www.npr.org/sections/health-shots/2015/11/24/456671203/more-women-are-fr....
-
- Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2013 assisted reproductive technology fertility clinic success rates report. Atlanta, GA: US Department of Health and Human Services; 2015.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical